Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Jeffrey Montgomery

Concepts (437)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Urinary Bladder Neoplasms
52
2024
158
9.770
Why?
Cystectomy
31
2024
49
6.230
Why?
Prostatic Neoplasms
43
2024
384
5.050
Why?
Kidney Neoplasms
22
2018
174
2.750
Why?
Carcinoma, Transitional Cell
13
2023
51
2.670
Why?
Prostatectomy
22
2023
82
2.340
Why?
Nephrectomy
19
2016
81
1.980
Why?
Lymph Node Excision
7
2024
131
1.810
Why?
Urinary Diversion
6
2021
44
1.620
Why?
Prostate
14
2024
114
1.530
Why?
Laparoscopy
13
2014
173
1.530
Why?
Quality of Life
12
2023
851
1.440
Why?
Aged
81
2024
9741
1.330
Why?
Male
120
2024
25907
1.240
Why?
Middle Aged
87
2024
12611
1.180
Why?
Humans
149
2024
50503
1.170
Why?
Neoadjuvant Therapy
12
2024
120
1.130
Why?
Neoplasm Staging
25
2024
746
1.020
Why?
BCG Vaccine
7
2024
16
0.970
Why?
Robotics
8
2015
41
0.960
Why?
Retrospective Studies
52
2024
6263
0.910
Why?
Postoperative Complications
15
2021
1033
0.910
Why?
Carcinoma, Renal Cell
10
2016
101
0.900
Why?
Penile Neoplasms
3
2024
44
0.880
Why?
Exercise Therapy
1
2023
96
0.820
Why?
Ureter
3
2016
37
0.810
Why?
Exercise
2
2023
516
0.800
Why?
Hernia
2
2020
6
0.760
Why?
Neoplasm Recurrence, Local
15
2024
629
0.710
Why?
Intestine, Small
2
2020
110
0.710
Why?
Herniorrhaphy
1
2020
26
0.690
Why?
Treatment Outcome
30
2024
5283
0.690
Why?
Physical Fitness
1
2020
60
0.680
Why?
Intestinal Obstruction
1
2020
36
0.680
Why?
Patient Readmission
6
2021
227
0.670
Why?
Aged, 80 and over
26
2024
3226
0.650
Why?
Image-Guided Biopsy
6
2024
33
0.650
Why?
Watchful Waiting
7
2019
26
0.630
Why?
Biopsy
17
2023
588
0.610
Why?
Ureteral Neoplasms
2
2018
11
0.600
Why?
Neoplasm Invasiveness
14
2024
269
0.600
Why?
Female
59
2024
27081
0.570
Why?
Testicular Neoplasms
4
2024
45
0.550
Why?
Magnetic Resonance Imaging
10
2023
1548
0.540
Why?
Urinary Bladder
7
2018
93
0.540
Why?
Convalescence
1
2016
6
0.530
Why?
Carcinoma, Squamous Cell
4
2024
326
0.530
Why?
Neoplasms, Germ Cell and Embryonal
3
2024
23
0.500
Why?
Prospective Studies
17
2024
2378
0.490
Why?
Urothelium
4
2018
17
0.490
Why?
Carcinoma in Situ
4
2024
73
0.480
Why?
Chemotherapy, Adjuvant
8
2024
121
0.480
Why?
Ileum
1
2014
85
0.460
Why?
Urologic Neoplasms
3
2019
12
0.460
Why?
Choline
3
2019
63
0.450
Why?
Neoplasm Grading
13
2020
122
0.450
Why?
Medical Oncology
4
2021
98
0.440
Why?
Quality Indicators, Health Care
1
2013
87
0.400
Why?
Needles
3
2021
25
0.400
Why?
Administration, Intravesical
7
2024
16
0.390
Why?
Urologic Surgical Procedures
3
2016
27
0.390
Why?
Disease Progression
8
2024
829
0.390
Why?
Antineoplastic Agents
3
2021
1172
0.380
Why?
Lymphatic Metastasis
4
2024
222
0.380
Why?
Biopsy, Needle
5
2021
178
0.370
Why?
Survival Rate
9
2021
909
0.370
Why?
Prostate-Specific Antigen
8
2021
44
0.370
Why?
Testicular Diseases
1
2011
4
0.370
Why?
Risk Assessment
10
2019
1270
0.360
Why?
Urogenital Neoplasms
1
2010
9
0.350
Why?
Tumor Burden
6
2016
130
0.350
Why?
Magnetic Resonance Imaging, Interventional
4
2024
5
0.350
Why?
Muscle Neoplasms
1
2010
16
0.350
Why?
Registries
4
2023
563
0.340
Why?
Fluorine Radioisotopes
2
2019
24
0.330
Why?
Retroperitoneal Space
5
2016
27
0.330
Why?
Antineoplastic Combined Chemotherapy Protocols
4
2024
1000
0.330
Why?
Recovery of Function
2
2023
191
0.320
Why?
Adult
27
2024
13577
0.320
Why?
Psoas Muscles
2
2021
2
0.320
Why?
Self Report
1
2010
206
0.320
Why?
Organ Sparing Treatments
4
2018
56
0.310
Why?
Telomerase
2
2019
26
0.310
Why?
Patient Selection
5
2019
259
0.300
Why?
Urinary Incontinence
3
2023
38
0.290
Why?
Deoxycytidine
3
2024
30
0.290
Why?
Seat Belts
2
2017
17
0.290
Why?
Child Restraint Systems
2
2017
18
0.290
Why?
Urinary Catheterization
1
2007
24
0.290
Why?
Positron-Emission Tomography
2
2019
292
0.290
Why?
Urethral Stricture
1
2007
21
0.280
Why?
Time Factors
13
2020
2935
0.280
Why?
Primary Health Care
1
2011
366
0.280
Why?
Rectum
2
2024
52
0.270
Why?
Cohort Studies
8
2021
1452
0.270
Why?
Tomography, X-Ray Computed
3
2021
1164
0.260
Why?
Length of Stay
6
2020
629
0.260
Why?
Guideline Adherence
3
2017
136
0.260
Why?
Health Status
2
2015
299
0.250
Why?
Patient Discharge
3
2017
321
0.250
Why?
Pain Measurement
2
2017
270
0.250
Why?
Kidney
4
2014
696
0.240
Why?
Patient Participation
2
2016
70
0.240
Why?
Bandages
1
2005
25
0.240
Why?
Carcinoma
2
2018
137
0.240
Why?
Adenoviridae
2
2024
48
0.240
Why?
Surgical Wound Infection
1
2005
115
0.230
Why?
Neurilemmoma
1
2004
25
0.230
Why?
Quality Improvement
3
2016
209
0.230
Why?
Antimetabolites, Antineoplastic
1
2024
35
0.230
Why?
Multivariate Analysis
8
2016
583
0.230
Why?
Age Factors
7
2021
1110
0.230
Why?
Adenocarcinoma
3
2016
397
0.230
Why?
Immunohistochemistry
5
2024
957
0.230
Why?
Organoids
1
2024
36
0.230
Why?
Venous Thrombosis
1
2005
87
0.230
Why?
Perineum
1
2024
24
0.220
Why?
Follow-Up Studies
9
2024
2242
0.220
Why?
Antibiotic Prophylaxis
1
2024
62
0.220
Why?
Decision Making
2
2016
272
0.210
Why?
Clinical Competence
3
2016
398
0.210
Why?
Practice Guidelines as Topic
2
2018
468
0.210
Why?
Prognosis
9
2021
1978
0.200
Why?
Urethra
3
2014
91
0.200
Why?
Erectile Dysfunction
3
2023
90
0.200
Why?
United States
12
2020
4955
0.200
Why?
DNA, Neoplasm
2
2018
143
0.190
Why?
Logistic Models
7
2021
900
0.190
Why?
Vital Statistics
1
2021
3
0.190
Why?
Feasibility Studies
2
2020
390
0.190
Why?
Mandatory Reporting
1
2021
11
0.190
Why?
Death Certificates
1
2021
17
0.180
Why?
DNA Mutational Analysis
3
2018
175
0.180
Why?
Cell Transdifferentiation
1
2021
8
0.180
Why?
Birth Certificates
1
2021
25
0.180
Why?
Cost-Benefit Analysis
2
2019
266
0.180
Why?
Neuroendocrine Cells
1
2021
10
0.180
Why?
Reproducibility of Results
7
2018
1197
0.180
Why?
Urethral Diseases
2
2013
7
0.180
Why?
Radiosurgery
1
2022
123
0.180
Why?
Radiography, Abdominal
1
2020
26
0.180
Why?
Mutation
5
2019
1280
0.180
Why?
Reimbursement, Incentive
1
2020
13
0.170
Why?
Genetic Vectors
1
2020
128
0.170
Why?
Randomized Controlled Trials as Topic
4
2023
573
0.170
Why?
Genetic Therapy
1
2020
120
0.170
Why?
Ablation Techniques
1
2019
22
0.170
Why?
Abdominal Pain
1
2020
83
0.160
Why?
Venous Thromboembolism
1
2020
74
0.160
Why?
Diagnosis, Differential
2
2020
1033
0.160
Why?
Genetic Predisposition to Disease
5
2024
511
0.160
Why?
Adjuvants, Immunologic
3
2024
51
0.160
Why?
Urinary Tract
1
2018
26
0.160
Why?
Lymphocytes
1
2019
149
0.160
Why?
Forecasting
1
2019
147
0.160
Why?
Predictive Value of Tests
6
2018
930
0.160
Why?
Patient-Centered Care
1
2020
130
0.150
Why?
Obesity
2
2006
1121
0.150
Why?
RNA, Neoplasm
1
2018
43
0.150
Why?
Drug Resistance, Neoplasm
1
2020
316
0.150
Why?
Genetic Heterogeneity
1
2018
17
0.150
Why?
Neutrophils
1
2019
145
0.150
Why?
Programmed Cell Death 1 Receptor
1
2018
39
0.150
Why?
Retroperitoneal Neoplasms
1
2018
17
0.150
Why?
Orchiectomy
1
2018
38
0.150
Why?
Transurethral Resection of Prostate
1
2018
10
0.150
Why?
Internship and Residency
2
2021
447
0.150
Why?
Pain, Postoperative
2
2016
163
0.150
Why?
Body Size
1
2017
26
0.150
Why?
Electronic Health Records
1
2020
220
0.140
Why?
Quality Assurance, Health Care
1
2018
150
0.140
Why?
Physician-Patient Relations
2
2016
142
0.140
Why?
Anticoagulants
1
2020
256
0.140
Why?
Databases, Factual
2
2021
673
0.140
Why?
Inguinal Canal
1
2017
11
0.140
Why?
Urodynamics
2
2014
22
0.140
Why?
Sarcosine
1
2017
3
0.140
Why?
Amino Acid Transport Systems
1
2017
5
0.140
Why?
Body Height
1
2017
64
0.140
Why?
Transcriptome
2
2018
313
0.140
Why?
Carbon Radioisotopes
1
2017
53
0.140
Why?
Safety
1
2017
77
0.140
Why?
Guidelines as Topic
1
2017
109
0.140
Why?
Disease-Free Survival
5
2016
444
0.140
Why?
Replantation
1
2016
11
0.130
Why?
Scrotum
2
2015
30
0.130
Why?
Protons
1
2017
67
0.130
Why?
Nomograms
1
2016
6
0.130
Why?
Laparotomy
1
2016
35
0.130
Why?
Natural Orifice Endoscopic Surgery
1
2016
4
0.130
Why?
Research Report
1
2016
16
0.130
Why?
Kaplan-Meier Estimate
5
2017
464
0.130
Why?
Physicians
2
2016
232
0.130
Why?
Urinary Retention
2
2007
7
0.130
Why?
Patient Preference
1
2016
40
0.130
Why?
Checklist
1
2016
29
0.130
Why?
Ureteral Obstruction
1
2016
61
0.130
Why?
Time-to-Treatment
1
2016
73
0.130
Why?
Preoperative Period
3
2021
48
0.120
Why?
Genital Neoplasms, Male
1
2015
2
0.120
Why?
Paget Disease, Extramammary
1
2015
5
0.120
Why?
Sensitivity and Specificity
5
2018
859
0.120
Why?
Social Networking
1
2015
14
0.120
Why?
Body Weight
1
2017
517
0.120
Why?
Lymph Nodes
1
2017
257
0.120
Why?
Feedback
1
2015
53
0.120
Why?
Radiopharmaceuticals
1
2016
204
0.120
Why?
Video Recording
1
2015
79
0.120
Why?
Peer Group
1
2015
56
0.120
Why?
Treatment Failure
2
2017
118
0.120
Why?
Informed Consent
1
2015
97
0.120
Why?
Papilloma, Inverted
1
2014
1
0.120
Why?
Proto-Oncogene Proteins B-raf
1
2015
80
0.120
Why?
Equipment Design
3
2021
289
0.120
Why?
Computer Simulation
1
2015
279
0.110
Why?
Proto-Oncogene Proteins p21(ras)
1
2014
67
0.110
Why?
Blood Loss, Surgical
5
2016
68
0.110
Why?
Matched-Pair Analysis
1
2013
11
0.110
Why?
Kidney Diseases
1
2016
213
0.110
Why?
Urinary Incontinence, Stress
1
2014
30
0.110
Why?
Diffusion of Innovation
1
2013
45
0.110
Why?
Carcinoma, Papillary
1
2014
47
0.110
Why?
Adenoma
1
2015
113
0.110
Why?
General Surgery
1
2015
108
0.110
Why?
Body Mass Index
3
2020
677
0.110
Why?
Technology Transfer
1
2013
2
0.110
Why?
Mitomycin
1
2013
20
0.110
Why?
Longitudinal Studies
2
2018
735
0.110
Why?
Radiotherapy, Adjuvant
2
2018
64
0.100
Why?
Severity of Illness Index
2
2014
978
0.100
Why?
Accreditation
1
2013
61
0.100
Why?
Peripheral Nerves
1
2013
48
0.100
Why?
Education, Medical, Continuing
1
2013
71
0.100
Why?
Operating Rooms
1
2012
27
0.100
Why?
Community Health Centers
1
2012
30
0.100
Why?
Pathology, Clinical
1
2012
24
0.100
Why?
Referral and Consultation
2
2012
288
0.100
Why?
Receptors, Androgen
2
2002
45
0.100
Why?
Algorithms
1
2015
625
0.100
Why?
Combined Modality Therapy
3
2021
641
0.090
Why?
Neoplasms
1
2021
1251
0.090
Why?
Risk Factors
5
2017
3724
0.090
Why?
Perioperative Care
1
2011
42
0.090
Why?
Seminal Vesicles
2
2022
13
0.090
Why?
Skin Neoplasms
1
2015
491
0.080
Why?
Multicenter Studies as Topic
2
2023
89
0.080
Why?
Medicare
3
2020
247
0.080
Why?
Phantoms, Imaging
2
2020
122
0.080
Why?
Proportional Hazards Models
3
2016
415
0.080
Why?
Markov Chains
2
2019
30
0.080
Why?
Immunotherapy
1
2010
235
0.080
Why?
Carboplatin
2
2022
54
0.080
Why?
SEER Program
3
2014
94
0.080
Why?
Postoperative Care
2
2020
104
0.080
Why?
Healthcare Disparities
1
2011
281
0.070
Why?
Ureteroscopy
1
2007
12
0.070
Why?
Automobiles
2
2017
13
0.070
Why?
Sarcopenia
2
2021
95
0.070
Why?
Pandemics
2
2023
563
0.070
Why?
Chi-Square Distribution
3
2013
277
0.070
Why?
Incidence
2
2021
1032
0.070
Why?
Diverticulum
1
2007
21
0.070
Why?
Peritoneum
1
2007
17
0.070
Why?
Delphi Technique
2
2018
55
0.070
Why?
Cisplatin
2
2022
286
0.070
Why?
Gene Amplification
2
2018
56
0.070
Why?
Aftercare
2
2018
72
0.070
Why?
Societies, Medical
2
2018
187
0.070
Why?
Gene Expression Profiling
2
2024
1025
0.070
Why?
Adrenalectomy
1
2006
35
0.070
Why?
Postoperative Hemorrhage
1
2006
52
0.070
Why?
Promoter Regions, Genetic
2
2019
465
0.070
Why?
Case-Control Studies
3
2014
1156
0.060
Why?
Fibrin Tissue Adhesive
1
2005
12
0.060
Why?
Sex Factors
2
2020
712
0.060
Why?
Hand
1
2005
48
0.060
Why?
Tissue Adhesives
1
2005
13
0.060
Why?
Genomics
2
2018
279
0.060
Why?
Intestines
1
2006
172
0.060
Why?
Suture Techniques
1
2005
57
0.060
Why?
Diabetes Complications
1
2005
116
0.060
Why?
Renal Insufficiency
1
2005
110
0.060
Why?
Chromosomes, Human, Pair 12
1
2024
13
0.060
Why?
Glomerular Filtration Rate
2
2016
119
0.060
Why?
Vulnerable Populations
1
2024
47
0.060
Why?
Drug Screening Assays, Antitumor
1
2024
131
0.060
Why?
Mediastinal Neoplasms
1
2024
16
0.060
Why?
Superior Mesenteric Artery Syndrome
1
2004
4
0.060
Why?
Communication
2
2016
250
0.060
Why?
Hernia, Inguinal
1
2004
18
0.060
Why?
Phenotype
2
2018
739
0.060
Why?
Intraoperative Complications
1
2005
114
0.060
Why?
High-Throughput Nucleotide Sequencing
2
2015
169
0.050
Why?
Cell Line, Tumor
2
2018
1398
0.050
Why?
Child
3
2024
6906
0.050
Why?
Neoplasms, Second Primary
1
2024
74
0.050
Why?
Quality of Health Care
2
2015
184
0.050
Why?
Ischemia
1
2004
153
0.050
Why?
Papillomavirus Infections
2
2015
168
0.050
Why?
Perioperative Period
2
2013
22
0.050
Why?
Trinucleotide Repeats
1
2002
2
0.050
Why?
Chromosome Aberrations
1
2024
280
0.050
Why?
Liver Cirrhosis
1
2005
229
0.050
Why?
Muscles
1
2022
104
0.050
Why?
Odds Ratio
2
2014
551
0.050
Why?
Polymorphism, Restriction Fragment Length
1
2002
59
0.050
Why?
Smoking
1
2005
507
0.050
Why?
Gallium Isotopes
1
2021
2
0.050
Why?
Accidents, Traffic
2
2017
88
0.050
Why?
Gallium Radioisotopes
1
2021
10
0.050
Why?
Edetic Acid
1
2021
14
0.050
Why?
Geography
1
2021
60
0.050
Why?
Radiotherapy, Intensity-Modulated
2
2013
177
0.050
Why?
Androgen Antagonists
1
2021
11
0.050
Why?
Polymorphism, Single Nucleotide
1
2024
475
0.050
Why?
Public Health
1
2023
199
0.050
Why?
Quarantine
1
2021
12
0.050
Why?
Internationality
1
2021
41
0.050
Why?
Neoplasm Metastasis
2
2017
232
0.050
Why?
Drug Dosage Calculations
1
2020
11
0.040
Why?
Motion
1
2020
19
0.040
Why?
Enoxaparin
1
2020
31
0.040
Why?
Finite Element Analysis
1
2020
10
0.040
Why?
Drug Monitoring
1
2020
79
0.040
Why?
Fellowships and Scholarships
1
2021
120
0.040
Why?
Pelvis
1
2020
66
0.040
Why?
DNA-Directed RNA Polymerases
1
2019
14
0.040
Why?
Abdomen
1
2020
75
0.040
Why?
Young Adult
2
2024
4102
0.040
Why?
Heparin
1
2020
91
0.040
Why?
Postoperative Period
1
2020
171
0.040
Why?
Social Behavior
1
2019
68
0.040
Why?
Urine
1
2018
24
0.040
Why?
Adolescent
2
2024
6443
0.040
Why?
Cytodiagnosis
1
2018
41
0.040
Why?
Diagnostic Errors
1
2018
66
0.040
Why?
Single-Blind Method
1
2018
114
0.040
Why?
DNA Copy Number Variations
1
2018
109
0.040
Why?
Genome, Human
1
2018
109
0.040
Why?
Quality-Adjusted Life Years
1
2018
63
0.040
Why?
Image Processing, Computer-Assisted
1
2019
243
0.040
Why?
Sequence Analysis, RNA
1
2018
88
0.040
Why?
Hospitalization
2
2017
675
0.040
Why?
Delivery of Health Care, Integrated
1
2018
47
0.040
Why?
Random Allocation
1
2018
289
0.040
Why?
Health Services Accessibility
2
2012
424
0.040
Why?
Nephrons
1
2016
6
0.030
Why?
Tissue Distribution
1
2017
166
0.030
Why?
Consensus
1
2018
160
0.030
Why?
Dose-Response Relationship, Drug
1
2020
1372
0.030
Why?
Hospital Communication Systems
1
2016
5
0.030
Why?
Coitus
1
2016
18
0.030
Why?
Failure to Thrive
1
2016
19
0.030
Why?
Anastomosis, Surgical
1
2016
66
0.030
Why?
Salvage Therapy
1
2017
137
0.030
Why?
Early Detection of Cancer
1
2018
163
0.030
Why?
Creatinine
1
2016
145
0.030
Why?
Radiometry
1
2017
123
0.030
Why?
Cyclin-Dependent Kinase 4
1
2015
11
0.030
Why?
Multiplex Polymerase Chain Reaction
1
2015
11
0.030
Why?
Genes, erbB-1
1
2015
8
0.030
Why?
Operative Time
1
2016
71
0.030
Why?
Tape Recording
1
2015
6
0.030
Why?
Fever
1
2016
112
0.030
Why?
Molecular Imaging
1
2016
54
0.030
Why?
Learning Curve
1
2015
18
0.030
Why?
Socioeconomic Factors
2
2011
591
0.030
Why?
Groin
1
2015
16
0.030
Why?
Tissue Array Analysis
1
2015
45
0.030
Why?
Oncology Service, Hospital
1
2014
14
0.030
Why?
Clinical Trials, Phase III as Topic
1
2015
45
0.030
Why?
Vinblastine
1
2014
22
0.030
Why?
Europe
1
2014
79
0.030
Why?
North America
1
2014
65
0.030
Why?
Regression Analysis
1
2015
382
0.030
Why?
Incontinence Pads
1
2014
2
0.030
Why?
In Situ Hybridization
1
2014
66
0.030
Why?
Kidney Failure, Chronic
1
2016
201
0.030
Why?
Amino Acid Substitution
1
2014
81
0.030
Why?
Personal Satisfaction
1
2014
78
0.030
Why?
Gene Dosage
1
2014
74
0.030
Why?
Gene Expression Regulation, Neoplastic
1
2018
833
0.030
Why?
Methotrexate
1
2014
72
0.030
Why?
Ultrasonography
1
2016
435
0.030
Why?
Anxiety
1
2016
285
0.030
Why?
United States Department of Veterans Affairs
1
2015
291
0.030
Why?
Survivors
1
2014
128
0.030
Why?
Papillomaviridae
1
2014
103
0.030
Why?
Dysuria
1
2013
1
0.030
Why?
Cluster Analysis
1
2014
219
0.030
Why?
Sequence Analysis, DNA
1
2014
226
0.030
Why?
Anesthesiology
1
2014
44
0.030
Why?
Prevalence
1
2016
971
0.030
Why?
Intention to Treat Analysis
1
2013
28
0.030
Why?
Valsalva Maneuver
1
2013
9
0.030
Why?
Stents
1
2016
350
0.030
Why?
Diagnostic Tests, Routine
1
2013
28
0.030
Why?
Paclitaxel
1
2013
84
0.030
Why?
Health Services Research
1
2013
152
0.030
Why?
Doxorubicin
1
2014
236
0.030
Why?
Confidence Intervals
1
2013
154
0.030
Why?
Antibiotics, Antineoplastic
1
2013
77
0.030
Why?
Neutropenia
1
2013
116
0.030
Why?
Thrombocytopenia
1
2013
81
0.020
Why?
Survival Analysis
1
2014
661
0.020
Why?
Angiomyolipoma
1
2012
10
0.020
Why?
Attitude of Health Personnel
1
2015
352
0.020
Why?
Unnecessary Procedures
1
2012
20
0.020
Why?
Tertiary Care Centers
1
2012
76
0.020
Why?
Neoplasm, Residual
1
2013
160
0.020
Why?
Pilot Projects
1
2014
698
0.020
Why?
Neoplasms, Multiple Primary
1
2012
42
0.020
Why?
Biopsy, Fine-Needle
1
2012
108
0.020
Why?
Patient Positioning
1
2011
32
0.020
Why?
Urination Disorders
1
2010
23
0.020
Why?
Disease Management
1
2012
178
0.020
Why?
Organ Size
1
2010
223
0.020
Why?
Comorbidity
1
2012
623
0.020
Why?
Health Status Disparities
1
2011
202
0.020
Why?
Intraoperative Period
1
2007
45
0.020
Why?
Erythrocyte Transfusion
1
2006
52
0.020
Why?
Costs and Cost Analysis
1
2006
90
0.020
Why?
Decision Trees
1
2005
19
0.020
Why?
Portal System
1
2005
17
0.020
Why?
Collateral Circulation
1
2005
39
0.020
Why?
Hypertension, Portal
1
2005
20
0.020
Why?
Reoperation
1
2006
460
0.010
Why?
Short Bowel Syndrome
1
2004
16
0.010
Why?
Blood Transfusion
1
2005
129
0.010
Why?
Necrosis
1
2004
174
0.010
Why?
Liver Transplantation
1
2005
154
0.010
Why?
Polymorphism, Genetic
1
2002
180
0.010
Why?
Genetic Markers
1
2002
104
0.010
Why?
Statistics, Nonparametric
1
2002
192
0.010
Why?
Base Sequence
1
2002
639
0.010
Why?
Polymerase Chain Reaction
1
2002
449
0.010
Why?
Molecular Sequence Data
1
2002
778
0.010
Why?
Montgomery's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description